A detailed history of Sofinnova Investments, Inc. transactions in Insmed Inc stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 227,747 shares of INSM stock, worth $16.7 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
227,747
Previous 100,000 127.75%
Holding current value
$16.7 Million
Previous $2.71 Million 462.44%
% of portfolio
0.85%
Previous 0.16%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$22.0 - $69.71 $5.01 Million - $15.9 Million
227,747 New
227,747 $15.3 Million
Q3 2022

Nov 08, 2022

BUY
$20.88 - $28.21 $4.45 Million - $6.02 Million
213,295 Added 2894.1%
220,665 $4.75 Million
Q2 2022

Aug 15, 2022

BUY
$17.07 - $25.71 $34,174 - $51,471
2,002 Added 37.3%
7,370 $145,000
Q1 2022

May 16, 2022

SELL
$20.42 - $28.13 $8.91 Million - $12.3 Million
-436,405 Reduced 98.78%
5,368 $126,000
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $2.42 Million - $3.12 Million
-93,347 Reduced 17.44%
441,773 $12 Million
Q3 2021

Nov 15, 2021

SELL
$22.46 - $29.47 $6.94 Million - $9.11 Million
-309,049 Reduced 36.61%
535,120 $14.7 Million
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $5.44 Million - $8.11 Million
225,219 Added 36.39%
844,169 $24 Million
Q1 2021

May 14, 2021

BUY
$32.28 - $44.3 $9.98 Million - $13.7 Million
309,288 Added 99.88%
618,950 $21.1 Million
Q4 2020

Feb 16, 2021

SELL
$31.45 - $40.54 $9.61 Million - $12.4 Million
-305,481 Reduced 49.66%
309,662 $10.3 Million
Q3 2020

Nov 13, 2020

BUY
$26.0 - $34.5 $3.41 Million - $4.53 Million
131,176 Added 27.1%
615,143 $19.8 Million
Q2 2020

Aug 13, 2020

BUY
$14.11 - $29.42 $6.83 Million - $14.2 Million
483,967 New
483,967 $13.3 Million
Q2 2019

Aug 13, 2019

SELL
$23.0 - $32.19 $3.22 Million - $4.51 Million
-140,057 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$13.91 - $31.15 $1.95 Million - $4.36 Million
140,057 New
140,057 $4.07 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.93B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.